Status:
UNKNOWN
Plan for Microwave Thermal Field
Lead Sponsor:
Chinese PLA General Hospital
Conditions:
Hepatocellular Carcinoma
Ablation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Develop an intelligent system based on contrast-enhanced ultrasound and clinical information to help doctors automatically obtain ablation parameters (ablation needle number, ablation needle type, abl...
Eligibility Criteria
Inclusion
- Biopsy or clinical diagnosis of HCC
- Complete clinical information and preoperative CEUS
- Curative treatment
Exclusion
- Palliative care
- Intolerance to ablation
- Severe coagulation disorder
Key Trial Info
Start Date :
October 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2022
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT05270642
Start Date
October 1 2021
End Date
December 30 2022
Last Update
March 8 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chinese PLA General Hospital
Beijing, Beijing Municipality, China, 100853